tiprankstipranks
Advertisement
Advertisement
Immunocore Shareholders Back All Proposals at 2026 AGM
PremiumCompany AnnouncementsImmunocore Shareholders Back All Proposals at 2026 AGM
2M ago
Immunocore reports Q1 EPS 25c, consensus (26c)
Premium
The Fly
Immunocore reports Q1 EPS 25c, consensus (26c)
3M ago
Needham’s Gil Blum Reiterates Buy on Strong Execution, Robust Pipeline and Solid Cash Runway, Keeps $75 Price Target Unchanged
Premium
Ratings
Needham’s Gil Blum Reiterates Buy on Strong Execution, Robust Pipeline and Solid Cash Runway, Keeps $75 Price Target Unchanged
3M ago
Qualcomm, Adobe downgraded: Wall Street’s top analyst calls
PremiumThe FlyQualcomm, Adobe downgraded: Wall Street’s top analyst calls
5M ago
Immunocore downgraded to Hold from Buy at Jefferies
Premium
The Fly
Immunocore downgraded to Hold from Buy at Jefferies
5M ago
Immunocore: Strong KIMMTRAK Execution, Robust Late-Stage Pipeline, and Cash-Funded Catalysts Support Buy Rating and $100 Target
Premium
Ratings
Immunocore: Strong KIMMTRAK Execution, Robust Late-Stage Pipeline, and Cash-Funded Catalysts Support Buy Rating and $100 Target
5M ago
Immunocore announces R&D chief resignation and leadership reshuffle
PremiumCompany AnnouncementsImmunocore announces R&D chief resignation and leadership reshuffle
6M ago
Immunocore announces EVP, Research, Development Berman to depart
Premium
The Fly
Immunocore announces EVP, Research, Development Berman to depart
6M ago
Immunocore Sets 2026 Strategic Priorities for Melanoma Growth
Premium
Company Announcements
Immunocore Sets 2026 Strategic Priorities for Melanoma Growth
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100